Atopic Dermatitis News

 
 
  • ATS 2018Ozone Exposure Puts Kids at Risk for Asthma, Allergic Diseases Exposure to ozone in early life raises the risk for asthma and allergic rhinitis by about 80%, according to 10-year follow-up data from a Toronto birth cohort.
  • ATS 2018Dupilumab Helps Lung Function, Reduces Asthma Exacerbations The agent is effective for the treatment of uncontrolled asthma, new research shows, but because of the cost of it and the other biologics for asthma, head-to-head comparisons are needed.
  • Moisturizing Bath Washes May Not Help Kids With Eczema Children with eczema whose bath water contains added moisturizers may get no more relief from the itchy skin condition than they would without the extra bath products, a study suggests.
  • Just Living Close to Livestock Might Lower Allergy Risk Exposure to farms seems to reduce the risk of allergy sensitivity, even among adults, and living close to a livestock farm in particular might curb common allergies, a Dutch study suggests.
  • Allergies and Asthma May Be Linked to Mental Health People who suffer from asthma and allergic rhinitis have an increased risk for developing a psychiatric disorder, and assessing their emotional condition and monitoring their mental health might be worthwhile, say researchers from Taiwan.
  • Probiotics During Pregnancy Tied to Lower Eczema Risk for Kids Women who take probiotics while they’re pregnant and breastfeeding could be less likely to have children with eczema than mothers who don’t, a research review suggests.
  • AADOral Eczema Treatments Generate Excitement Impressive phase 2 results raise hope that oral medications will replace injections for atopic dermatitis.
  • AADImmune Modulation in the Spotlight at AAD 2018 Immunomodulators for inflammatory diseases and cancer will be among the hot topics at the upcoming American Academy of Dermatology meeting.
  • Regeneron CEO Says Fears Over Eylea 'Greatly Exaggerated' Fears of the demise of blockbuster eye drug Eylea (aflibercept) were "greatly exaggerated," Regeneron Pharmaceuticals Inc's chief executive said on Thursday, after the treatment and new eczema drug Dupixent (dupilumab) powered the company's fourth-quarter results.
  • Plain Water Baths as Effective as Bleach Baths for Eczema Bleach baths are no more effective for the treatment of eczema than plain water baths and may cause unpleasant adverse effects such as burning and stinging, a study found.
  • Prescription-Strength Steroid Creams Sold Without Prescription Although the U.S. requires prescriptions for topical steroids with more than a 0.5% concentration, much stronger and potentially harmful steroid creams are not hard to find without a prescription, doctors report.
  • ACAAIEczema Can Predict Severity of Asthma Hospitalization A family history of asthma and a patient's own history of atopic dermatitis are linked to a more severe hospital experience, according to a study that could influence care decisions.
  • Do Dogs Help Prevent Eczema and Asthma? Animals are a common trigger for eczema and asthma symptoms but two new US studies show dogs may not be the enemy they are often thought to be.
  • ACAAINew Drugs for Atopic Dermatitis Boost Treatment Options For decades there were few options for people with atopic dermatitis, but new choices, with more in the pipeline, have meant a substantial shift in treatment.
  • Dermatology Guideline Authors Take Big Payments From Industry Dermatology clinical practice guideline authors often receive large payments from industry and don't always fully disclose them, researchers report.
  • ACAAIFood Introduction, Chronic Cough Top Allergy Meeting Lineup The challenge of explaining updated guidelines on the introduction of peanut products will be among the topics addressed at the American College of Allergy, Asthma & Immunology (ACAAI) meeting.
  • Alert EU Approves Dupilumab (Dupixent) for Atopic Dermatitis The European Commission has granted marketing authorization to dupilumab for adults with moderate to severe atopic dermatitis, according to a company news release.
  • Lilly/Incyte Pill Beats Placebo in Mid-stage Eczema Trial Eli Lilly and Co and Incyte Corp on Thursday said a mid-stage trial of their oral drug baricitinib showed that at the highest dose it worked better than placebo for people with moderate-to-severe atopic dermatitis.
  • Moisturizers Labeled 'Hypoallergenic' May Still Have Toxic Chemicals Many moisturizers promoted as remedies for skin problems like eczema and labeled as `fragrance-free’ or `hypoallergenic’ may still contain chemicals that can cause irritation, a recent U.S. study suggests.
  • EADVImmunotherapies Center Stage at EADV The designated hot topic of this year's European Academy of Dermatology and Venereology (EADV) Congress will have specialists talking about the latest developments in immunotherapies.